| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |